SavedAdd your journal

Journals / Acta Medica Anatolia / 2015 / Cilt: 3 - Sayı: 1

Kontrast İlişkili Nefropati; Yüksek Riskli Hastalarda Önleme Stratejileri

Contrast-Induced Nephropathy; Prevention Strategies In High-Risk Patients

Kerem ÖZBEK
Metin KARAYAKALI
Ayşegül ALTUNKAŞ
Arif ARISOY
Fatih ALTUNKAŞ
Köksal CEYHAN
FATİH KOÇ
Pages
35–38
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The first aim to prevent CIN is identifying high-risk subjects and controlling associate risk factors.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Contrast-induced nephropathy (CIN) is a complication which may develop after exposure to iodinated contrast media.
📊
Key Findings & Data:Incidence of CIN in the general population is estimated to be less than 2% but in high-risk patients CIN incidences have been reported approximately 50%.
💡
Conclusion & Impact:The first aim to prevent CIN is identifying high-risk subjects and controlling associate risk factors.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Contrast-induced nephropathy (CIN) is a complication which may develop after exposure to iodinated contrast media. Incidence of CIN in the general population is estimated to be less than 2% but in high-risk patients CIN incidences have been reported approximately 50%. The first aim to prevent CIN is identifying high-risk subjects and controlling associate risk factors.

Özet

Kontrast ilişkili nefropati (KİN) iyotlu kontrast ortama maruziyet sonrasında gelişebilen bir komplikasyondur. Genel popülasyonda KİN insidansının %2’den düşük olduğu tahmin edilmektedir, fakat yüksek riskli hastalarda KKn insidansınn %50 civarında olduğu bildirilmiştir. KİN’nin önlenmesinde ilk amaç yüksek riskli bireylerin tanımlanması ve ilişkili risk faktörlerinin kontrolüdür.

🔖

Cite This Article

ÖZBEK, K., KARAYAKALI, M., ALTUNKAŞ, A., ARISOY, A., ALTUNKAŞ, F., CEYHAN, K., KOÇ, F. (2015). Kontrast İlişkili Nefropati; Yüksek Riskli Hastalarda Önleme Stratejileri. Acta Medica Anatolia, Cilt: 3 - Sayı: 1, 35–38. https://ajindex.com/articles/148129

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Cruz DN, Goh CY, Marenzi G, Corradi V, Ronco C, Perazella MA. Renal replacement therapies for prevention of radiocontrast-induced nephropathy: a systematic review. Am J Med. 2012;125(1):66-78 e3
  2. Karayakali M. Ozbek K, Altunkas A., Karaman K., Altunkas F., Celik A., et al. Contrast-induced nephropathy: focused on risk factors. Acta Medica Anatolia. 2014;2(1):23- 37 3. Golshahi J, Nasri H, Gharipour M. Contrast-induced nephropathy; A literature review. J Nephropathol. 2014;3(2):51-56
  3. Mehran R, Nikolsky E. Contrast-induced nephropathy: definition, epidemiology, and patients at risk. Kidney Int Suppl. 2006;(100):11-15
  4. Andreucci M, Solomon R, Tasanarong A. Side effects of radiographic contrast media: pathogenesis, risk factors, and prevention. Biomed Res Int. 2014;2014:741018
  5. Solomon R, Barrett B. Follow-up of patients with contrast-induced nephropathy. Kidney Int Suppl. 2006;(100):46-50
  6. Marenzi G, Marana I, Lauri G, Assanelli E, Grazi M, Campodonico J, et al. The prevention of radiocontrastagent-induced nephropathy by hemofiltration. N Engl J Med. 2003;349(14):1333-1340
  7. Marenzi G, Lauri G, Campodonico J, Marana I, Assanelli E, De Metrio M, et al. Comparison of two hemofiltration protocols for prevention of contrast-induced nephropathy in high-risk patients. Am J Med. 2006;119(2):155-162
  8. Pucelikova T, Dangas G, Mehran R. Contrast-induced nephropathy. Catheter Cardiovasc Interv. 2008;71(1):62-72
  9. McCullough PA, Adam A, Becker CR, Davidson C, Lameire N, Stacul F, et al. Risk prediction of contrastinduced nephropathy. Am J Cardiol. 2006;98(6A):27K-36K
  10. Marenzi G, Assanelli E, Marana I, Lauri G, Campodonico J, Grazi M, et al. N-acetylcysteine and contrast-induced nephropathy in primary angioplasty. N Engl J Med. 2006;354(26):2773-2782
  11. Mueller C, Buerkle G, Buettner HJ, Petersen J, Perruchoud AP, Eriksson U, et al. Prevention of contrast media-associated nephropathy: randomized comparison of 2 hydration regimens in 1620 patients undergoing coronary angioplasty. Arch Intern Med. 2002;162(3):329-336
  12. Tepel M, van der Giet M, Schwarzfeld C, Laufer U, Liermann D, Zidek W. Prevention of radiographic-contrastagent-induced reductions in renal function by acetylcysteine. N Engl J Med. 2000;343(3):180-184
  13. Koc F, Ozdemir K, Kaya MG, Dogdu O, Vatankulu MA, Ayhan S, et al. Intravenous N-acetylcysteine plus high-dose hydration versus high-dose hydration and standard hydration for the prevention of contrast-induced nephropathy: